GUGGENHEIM CAPITAL LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 193 filers reported holding HAEMONETICS CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$1,154,910
-7.5%
13,960
-4.6%
0.01%
-11.1%
Q1 2024$1,248,671
+30.6%
14,630
+30.8%
0.01%
+28.6%
Q4 2023$956,344
+17.9%
11,184
+23.6%
0.01%0.0%
Q3 2023$810,879
-1.4%
9,052
-13.5%
0.01%0.0%
Q4 2022$822,600
-8.0%
10,459
-13.4%
0.01%
-12.5%
Q3 2022$894,000
+12.5%
12,078
-1.1%
0.01%
+33.3%
Q2 2022$795,000
-2.3%
12,210
-5.1%
0.01%
+20.0%
Q1 2022$814,000
+24.3%
12,867
+4.3%
0.01%
+66.7%
Q4 2021$655,000
-32.8%
12,342
-10.5%
0.00%
-50.0%
Q3 2021$974,000
+30.0%
13,797
+22.7%
0.01%
+50.0%
Q2 2021$749,000
-27.8%
11,243
+20.3%
0.00%
-42.9%
Q1 2021$1,038,000
+138.1%
9,349
+154.5%
0.01%
+133.3%
Q4 2020$436,000
+85.5%
3,674
+55.7%
0.00%
+50.0%
Q1 2020$235,000
-36.7%
2,359
-27.0%
0.00%
-33.3%
Q4 2019$371,000
-48.3%
3,231
-43.2%
0.00%
-50.0%
Q3 2019$717,000
+33.8%
5,687
+27.6%
0.01%
+50.0%
Q2 2019$536,000
+25.5%
4,458
-8.7%
0.00%
+33.3%
Q1 2019$427,000
-23.3%
4,882
-12.2%
0.00%
-40.0%
Q4 2018$557,000
+167.8%
5,563
-6.3%
0.01%
Q3 2014$208,000
+3.0%
5,938
+3.3%
0.00%
-100.0%
Q2 2014$202,0000.0%5,747
-6.9%
0.00%0.0%
Q1 2014$202,000
-35.3%
6,173
-21.0%
0.00%0.0%
Q3 2013$312,000
-4.0%
7,813
-0.6%
0.00%0.0%
Q2 2013$325,0007,8610.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2013
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders